Clinical trial
Genome Expression in Lymphoma, Leukemia and Multiple Myeloma
NCT00339963 · National Cancer Institute (NCI), NIH · Completed
Key facts
| NCT number | NCT00339963 |
|---|---|
| Title | Genome Expression in Lymphoma, Leukemia and Multiple Myeloma |
| Official title | Expression of the Genome in Lymphoid Malignancies |
| Lead sponsor | National Cancer Institute (NCI), NIH |
| Collaborators | Lymphoma/Leukemia Molecular Profiling Project (LLMPP) |
| Status | Completed |
| Study type | Observational |
| Conditions | Leukemia, Multiple Myeloma, Hodgkin Lymphoma, Lymphoma, Non-Hodgkin |
| Enrollment | 1,340 |
| Start date | Nov 9, 2001 |
| First posted | Jun 21, 2006 |
| Last update posted | Jan 16, 2026 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: